Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (abre una nueva ventana)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Fuente‎: Intensive Care Med 2013;39(11):2011-9.

Indexado en‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (abre una nueva ventana)

Pediatric red blood cell transfusions increase resource use. (abre una nueva ventana)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Fuente‎: J Pediatr 2003;142(2):123-7.

Indexado en‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (abre una nueva ventana)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (abre una nueva ventana)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Fuente‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Indexado en‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (abre una nueva ventana)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (abre una nueva ventana)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Fuente‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Indexado en‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (abre una nueva ventana)

Economic evaluation of cell salvage in pediatric surgery. (abre una nueva ventana)

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM.

Fuente‎: Paediatr Anaesth 2013;23(11):1027-34.

Indexado en‎: PubMed 23952976

DOI‎: 10.1111/pan.12233

https://www.ncbi.nlm.nih.gov/pubmed/23952976 (abre una nueva ventana)